newsfilter
← Latest News
Business Wire·

Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference

Posters Highlight New Insights into Social Anxiety Disorder and the Novel Mechanism of Action of Itruvone to Treat Major Depressive Disorder Vistagen (NASDAQ:VTGN), a clinical-stage biopharmaceutical company pioneering